chr3-136948274-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001291999.2(NCK1):c.955G>A(p.Val319Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000096 in 1,593,664 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001291999.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NCK1 | NM_001291999.2 | c.955G>A | p.Val319Ile | missense_variant | 4/4 | ENST00000481752.6 | NP_001278928.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NCK1 | ENST00000481752.6 | c.955G>A | p.Val319Ile | missense_variant | 4/4 | 5 | NM_001291999.2 | ENSP00000417273.1 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 151838Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000672 AC: 16AN: 237928Hom.: 0 AF XY: 0.0000700 AC XY: 9AN XY: 128506
GnomAD4 exome AF: 0.0000909 AC: 131AN: 1441826Hom.: 0 Cov.: 30 AF XY: 0.0000963 AC XY: 69AN XY: 716686
GnomAD4 genome AF: 0.000145 AC: 22AN: 151838Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74150
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 15, 2021 | The c.955G>A (p.V319I) alteration is located in exon 4 (coding exon 3) of the NCK1 gene. This alteration results from a G to A substitution at nucleotide position 955, causing the valine (V) at amino acid position 319 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at